Explore All 2734 Add-on Acquisition Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | May 30, 2008 |
| Target | Protiva Biotherapeutics |
| Sector | Medical Products |
| Buyer(s) | Arbutus Biopharma |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Sector | Life Science |
| Employees | 44 |
| Revenue | 6M USD (2024) |
Arbutus Biopharma is a biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). Arbutus Biopharma is based in Warminster, Pennsylvania.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Medical Products | 1 of 1 |
| Type: Add-on Acquisition | 1 of 1 |
| State: British Columbia | 1 of 1 |
| Country: Canada | 1 of 1 |
| Year: 2008 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-03-04 |
OnCore Biopharma
Doylestown, Pennsylvania, United States OnCore Biopharma, Inc. is a biopharmaceutical company provides research, development, and commercialization of therapies. |
Buy | - |
